CN112753777A - Milk powder for improving immunity and preparation method thereof - Google Patents
Milk powder for improving immunity and preparation method thereof Download PDFInfo
- Publication number
- CN112753777A CN112753777A CN202110113235.1A CN202110113235A CN112753777A CN 112753777 A CN112753777 A CN 112753777A CN 202110113235 A CN202110113235 A CN 202110113235A CN 112753777 A CN112753777 A CN 112753777A
- Authority
- CN
- China
- Prior art keywords
- milk powder
- powder
- compound
- parts
- improving immunity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 139
- 235000013336 milk Nutrition 0.000 title claims abstract description 60
- 239000008267 milk Substances 0.000 title claims abstract description 60
- 210000004080 milk Anatomy 0.000 title claims abstract description 60
- 230000036039 immunity Effects 0.000 title claims abstract description 54
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 150000001875 compounds Chemical class 0.000 claims abstract description 39
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 30
- 238000003756 stirring Methods 0.000 claims abstract description 29
- 229940088594 vitamin Drugs 0.000 claims abstract description 23
- 229930003231 vitamin Natural products 0.000 claims abstract description 23
- 235000013343 vitamin Nutrition 0.000 claims abstract description 23
- 239000011782 vitamin Substances 0.000 claims abstract description 23
- 150000004676 glycans Chemical class 0.000 claims abstract description 20
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 20
- 239000011707 mineral Substances 0.000 claims abstract description 20
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 20
- 239000005017 polysaccharide Substances 0.000 claims abstract description 20
- 239000006041 probiotic Substances 0.000 claims abstract description 19
- 235000018291 probiotics Nutrition 0.000 claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 18
- 241000222336 Ganoderma Species 0.000 claims abstract description 16
- 235000020183 skimmed milk Nutrition 0.000 claims abstract description 16
- 235000008939 whole milk Nutrition 0.000 claims abstract description 16
- 241000283690 Bos taurus Species 0.000 claims abstract description 15
- 102000010445 Lactoferrin Human genes 0.000 claims abstract description 15
- 108010063045 Lactoferrin Proteins 0.000 claims abstract description 15
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 15
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 15
- 210000003022 colostrum Anatomy 0.000 claims abstract description 15
- 235000021277 colostrum Nutrition 0.000 claims abstract description 15
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims abstract description 15
- 150000003271 galactooligosaccharides Chemical class 0.000 claims abstract description 15
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims abstract description 15
- 235000021242 lactoferrin Nutrition 0.000 claims abstract description 15
- 229940078795 lactoferrin Drugs 0.000 claims abstract description 15
- 239000008101 lactose Substances 0.000 claims abstract description 15
- 229960003080 taurine Drugs 0.000 claims abstract description 15
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims abstract description 12
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 12
- 238000007873 sieving Methods 0.000 claims abstract description 11
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims abstract description 7
- 102000004407 Lactalbumin Human genes 0.000 claims abstract description 7
- 108090000942 Lactalbumin Proteins 0.000 claims abstract description 7
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims abstract description 7
- 238000010298 pulverizing process Methods 0.000 claims abstract description 6
- 238000005303 weighing Methods 0.000 claims abstract description 6
- 240000008397 Ganoderma lucidum Species 0.000 claims description 22
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 22
- 235000010755 mineral Nutrition 0.000 claims description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- 241000894006 Bacteria Species 0.000 claims description 12
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 10
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 10
- 235000017784 Mespilus germanica Nutrition 0.000 claims description 10
- 235000000560 Mimusops elengi Nutrition 0.000 claims description 10
- 235000007837 Vangueria infausta Nutrition 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 10
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 9
- 102000007544 Whey Proteins Human genes 0.000 claims description 8
- 108010046377 Whey Proteins Proteins 0.000 claims description 8
- 235000021119 whey protein Nutrition 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 7
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 241000186000 Bifidobacterium Species 0.000 claims description 5
- 241001134770 Bifidobacterium animalis Species 0.000 claims description 5
- 108010059892 Cellulase Proteins 0.000 claims description 5
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 claims description 5
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 claims description 5
- 229940118852 bifidobacterium animalis Drugs 0.000 claims description 5
- 229940106157 cellulase Drugs 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 5
- 239000012153 distilled water Substances 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 239000011706 ferric diphosphate Substances 0.000 claims description 5
- 235000007144 ferric diphosphate Nutrition 0.000 claims description 5
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 claims description 5
- 229940036404 ferric pyrophosphate Drugs 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 230000001376 precipitating effect Effects 0.000 claims description 5
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 5
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims description 5
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims description 5
- 229960004172 pyridoxine hydrochloride Drugs 0.000 claims description 5
- 229960000342 retinol acetate Drugs 0.000 claims description 5
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 claims description 5
- 235000019173 retinyl acetate Nutrition 0.000 claims description 5
- 239000011770 retinyl acetate Substances 0.000 claims description 5
- 235000005282 vitamin D3 Nutrition 0.000 claims description 5
- 239000011647 vitamin D3 Substances 0.000 claims description 5
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 5
- 229940021056 vitamin d3 Drugs 0.000 claims description 5
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 5
- 229960001763 zinc sulfate Drugs 0.000 claims description 5
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 5
- 241001465754 Metazoa Species 0.000 claims description 3
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 claims description 3
- ZAKOWWREFLAJOT-UHFFFAOYSA-N DL-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 2
- 229940117373 dl-alpha tocopheryl acetate Drugs 0.000 claims description 2
- 239000011755 sodium-L-ascorbate Substances 0.000 claims description 2
- 235000019187 sodium-L-ascorbate Nutrition 0.000 claims description 2
- 240000002624 Mespilus germanica Species 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 9
- 239000000203 mixture Substances 0.000 abstract description 4
- 229920002307 Dextran Polymers 0.000 abstract description 3
- 150000001720 carbohydrates Chemical group 0.000 abstract description 2
- 230000001900 immune effect Effects 0.000 abstract description 2
- 230000001953 sensory effect Effects 0.000 abstract description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 14
- 230000009286 beneficial effect Effects 0.000 description 14
- 230000006870 function Effects 0.000 description 10
- 210000001035 gastrointestinal tract Anatomy 0.000 description 9
- 235000015097 nutrients Nutrition 0.000 description 9
- 244000182216 Mimusops elengi Species 0.000 description 8
- 206010057249 Phagocytosis Diseases 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 229910052742 iron Inorganic materials 0.000 description 7
- 210000002540 macrophage Anatomy 0.000 description 7
- 230000008782 phagocytosis Effects 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000002131 composite material Substances 0.000 description 5
- -1 compound vitamin Chemical class 0.000 description 5
- 210000003743 erythrocyte Anatomy 0.000 description 5
- 235000019441 ethanol Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 210000000683 abdominal cavity Anatomy 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 235000001465 calcium Nutrition 0.000 description 4
- 210000000987 immune system Anatomy 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 230000000242 pagocytic effect Effects 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 3
- 244000241872 Lycium chinense Species 0.000 description 3
- 235000015468 Lycium chinense Nutrition 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 238000000643 oven drying Methods 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 235000014786 phosphorus Nutrition 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 229940042585 tocopherol acetate Drugs 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 230000001071 malnutrition Effects 0.000 description 2
- 235000000824 malnutrition Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 150000002772 monosaccharides Chemical group 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000033458 reproduction Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 2
- 229960005055 sodium ascorbate Drugs 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000036649 Dysbacteriosis Diseases 0.000 description 1
- 208000027244 Dysbiosis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- 238000002738 Giemsa staining Methods 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 102100033468 Lysozyme C Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029719 Nonspecific reaction Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000003815 abdominal wall Anatomy 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000007140 dysbiosis Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000010855 food raising agent Nutrition 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000020251 goat milk Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940088592 immunologic factor Drugs 0.000 description 1
- 239000000367 immunologic factor Substances 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 235000008521 threonine Nutrition 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000014393 valine Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1322—Inorganic compounds; Minerals, including organic salts thereof, oligo-elements; Amino-acids, peptides, protein-hydrolysates or derivatives; Nucleic acids or derivatives; Yeast extract or autolysate; Vitamins; Antibiotics; Bacteriocins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
- A23C9/206—Colostrum; Human milk
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses milk powder for improving immunity, which belongs to the technical field of milk products and comprises the following raw materials: skimmed milk powder, whole milk powder, bovine colostrum powder, fructus Lycii powder, ganoderan, concentrated lactalbumin, lactose, galactooligosaccharide, lactoferrin, yeast beta-glucan, taurine, compound vitamins, compound minerals and compound probiotics; the preparation method comprises the following steps: (1) weighing the raw materials; (2) stirring fructus Lycii powder, Ganoderma polysaccharide, concentrated lactalbumin, lactose, galactooligosaccharide, lactoferrin, yeast beta-dextran and taurine, pulverizing and sieving; (3) adding skimmed milk powder, whole milk powder, bovine colostrum powder, compound vitamins, compound minerals and compound probiotics, and stirring. The raw materials are compounded and cooperated, so that the composition of carbohydrate is improved, the immune effect of milk powder is enhanced under the condition of not influencing the sensory characteristics, and the milk powder has a good activity function, can improve the physique of a user and enhance the immune resistance.
Description
Technical Field
The invention belongs to the technical field of milk products, and particularly relates to milk powder for improving immunity and a preparation method thereof.
Background
The milk powder is prepared from fresh milk or goat milk by freezing or heating to remove almost all water in milk, drying, adding appropriate amount of vitamins and minerals, and making into instant food suitable for storage. However, with the pace of life and the increase of life pressure, modern people generally have the states of malnutrition, low immunity, sub-health and the like, and the appropriate supplement of milk powder is very necessary.
Immunity is the body's own defense mechanism, and is the body's ability to recognize and destroy any foreign body (virus, bacteria, etc.) that invades from the outside, to treat aged, damaged, dead, denatured self cells, and to recognize and treat mutant cells and virus-infected cells in the body. The lack of endogenous peptide in human body can cause low immune function, the body presents an intolerant state due to the low immune function, cold viruses enter in a deficiency mode and are infected concurrently, particularly the infection concurrent with influenza has serious illness and high death rate. The body with low immunity is easy to be infected or suffer from cancer, and the body can have harmful results due to high immunity, such as anaphylaxis, autoimmune diseases and the like.
The immune system cannot normally exert protective effect due to various reasons, and in this case, the immune system is very easy to infect bacteria, viruses, fungi and the like, so the most direct expression of low immunity is easy to cause diseases. The frequent illness aggravates the consumption of the organism, so the general manifestations of weak constitution, malnutrition, listlessness, fatigue, weakness, appetite reduction, sleep disorder and the like, the disease is caused, injection and medication are carried out to get home and dinner, the disease can be recovered for a long time after each occurrence of the disease, and the disease is frequently repeated, the physical and intelligence development is poor for a long time, and serious diseases are easily induced.
The deep cause is hypoimmunity or poor immunity. When the human body is immune dysfunctional or the immune system is not healthy, the following problems are repeatedly caused: the cold attacks repeatedly, the tonsillitis attacks repeatedly, the asthma attacks repeatedly, the bronchitis attacks repeatedly, the pneumonia attacks repeatedly, and the diarrhea attacks repeatedly, so that tens of millions of people cannot see the eyes.
At present, the milk powder on the market is full of milk and has higher price, but the milk powder with the efficacy of improving immunity does not appear.
Therefore, the development of a milk powder which is convenient to eat and transport and has the function of improving immunity is a problem to be solved by the technical personnel in the field.
Disclosure of Invention
In view of the above, the present invention provides a milk powder for improving immunity.
In order to achieve the purpose, the invention adopts the following technical scheme:
the milk powder for improving immunity comprises the following raw materials in parts by weight: 400 portions of skimmed milk powder, 200 portions of whole milk powder, 50 to 100 portions of bovine colostrum powder, 20 to 40 portions of medlar powder, 10 to 20 portions of ganoderma lucidum polysaccharide, 10 to 15 portions of concentrated whey protein, 2 to 6 portions of lactose, 1 to 3 portions of galacto-oligosaccharide, 0.5 to 0.7 portion of lactoferrin, 0.3 to 1.1 portion of yeast beta-glucan, 0.3 to 0.5 portion of taurine, 0.1 to 0.3 portion of vitamin complex, 0.5 to 2 portions of compound mineral substances and 0.2 to 1 portion of compound probiotics.
Preferably: 500 parts of skimmed milk powder, 150 parts of whole milk powder, 80 parts of bovine colostrum powder, 30 parts of medlar powder, 15 parts of ganoderan, 12 parts of concentrated whey protein, 5 parts of lactose, 2 parts of galacto-oligosaccharide, 0.6 part of lactoferrin, 0.8 part of yeast beta-glucan, 0.4 part of taurine, 0.2 part of vitamin complex, 1.2 parts of compound mineral substances and 0.6 part of compound probiotics.
The invention has the beneficial effects that:
the skimmed milk powder has low fat content, is easy to digest, has the function of protecting intestines and stomach, but has unbalanced nutrient components; the whole milk powder has balanced nutrient components, and the protein clot is fine, soft and easy to digest; the invention combines the skim milk powder and the whole milk powder, so that the nutrient components of the milk powder are more balanced and easier to absorb.
The bovine colostrum powder contains a large amount of immune factors, and can enhance the immunity of human bodies and reduce the occurrence of intestinal diseases.
The medlar is sweet in nature and mild in taste, enters liver and kidney channels, has the effects of nourishing liver and kidney, nourishing liver and improving eyesight, and is proved by modern medical research to contain carotene, betaine, vitamin A, vitamin B1, vitamin B2, vitamin C, calcium, phosphorus, iron and the like, has the pharmacological effects of increasing the activity of white blood cells and promoting the regeneration of liver cells, and also can reduce blood pressure, blood sugar and blood fat; importantly, the medlar has the function of enhancing nonspecific immunity, and the mice are infused with medlar water extract or intramuscular injection alcohol extract and medlar polysaccharide, so that the phagocytic function of macrophages is improved, the function of serum lysozyme is enhanced, the titer of anti-sheep red blood cell antibodies in serum is improved, and the number of anti-sheep red blood cell antibody forming cells in spleen of the mice can be increased.
Ganoderan is a glucan composed of three strands of monosaccharide chains and having a helical three-dimensional structure (tertiary structure), wherein most of the ganoderan contains monosaccharides such as arabinose, xylose, galactose, fucose, mannose, rhamnose and the like besides glucose; the ganoderan can improve the immunity of organisms, has special physiological activity and clinical effect, is safe and nontoxic, and can inhibit the release of an allergic reaction medium so as to block the occurrence of nonspecific reaction.
The concentrated whey protein can modify the protein structure, thereby greatly reducing the amount of antigen active substances and reducing the occurrence of atopic inflammation.
The beta-disaccharide in the lactose has a good regulating effect on the intestinal tract, is beneficial to the reproduction of beneficial flora such as lactobacillus in the intestinal tract, inhibits the growth of harmful flora in the intestinal tract, has a regulating effect on the digestive system of a human body, is beneficial to the health of the intestinal tract, simultaneously produces rich B vitamins, is beneficial to promoting the peristalsis of the intestinal tract and increasing the immunity of the human body.
The galactooligosaccharide is an excellent nutrient source and an effective proliferation factor of beneficial bacteria such as bifidobacterium, lactobacillus acidophilus and the like in human intestinal tracts, and can improve the digestion and absorption functions of the human intestines and stomach.
Lactoferrin not only participates in the transport of iron, but also has the powerful biological functions of broad-spectrum antibiosis, antioxidation, anticancer, immune system regulation and the like.
The yeast beta-glucan is a polysaccharide which exists in yeast cell walls and has the activity of enhancing immunity, is widely present in various fungi and plants, has strong immunity enhancing activity, and has the effects of improving blood fat, removing toxins, resisting radiation, repairing cells and improving intestinal functions.
Taurine has effects of regulating in vivo osmotic pressure, lowering blood sugar, and improving immunity.
Further, the above-mentioned vitamin complex is at least one of sodium L-ascorbate, dl-alpha-tocopheryl acetate, vitamin A acetate, cholecalciferol and pyridoxine hydrochloride.
The further technical scheme has the beneficial effects that the compound vitamin is added, so that the normal growth, reproduction and vision can be maintained, the epithelial tissue is promoted to be healthy, and the anti-infection immune function is enhanced; can prevent rickets and promote calcium absorption; can prevent the peroxidation of unsaturated fatty acid in milk powder and protect skin, and the addition of compound vitamin can improve immunity and protect intestines and stomach.
Further, the compound mineral is ferric pyrophosphate and/or zinc sulfate.
The beneficial effect of the further technical proposal is that zinc and iron participate in the synthesis and activation of various enzymes, and play an important role in the synthesis of protein nucleic acid and the digestion and absorption of intestinal protein.
Further, the composite probiotics are animal bifidobacteria and/or lactobacillus acidophilus; further, the Bifidobacterium animalis has a bacterial content of 1X 106-1×108CFU/g, the bacteria content of Lactobacillus acidophilus is 1 × 106-1×108CFU/g。
The beneficial effects of the further technical scheme are that the bifidobacteria can produce lactic acid and acetic acid after fermentation in human intestines, can improve the utilization rate of calcium, phosphorus and iron and promote the absorption of iron and vitamin D, and can produce vitamins B1, B2, B6 and B12, alanine, valine, aspartic acid, threonine and other nutrients necessary for human bodies.
The lactobacillus acidophilus can adjust the flora balance in intestinal tracts and inhibit the proliferation of undesirable microorganisms in the intestinal tracts, and the lactobacillus acidophilus and the bifidobacterium are mixed to form a leavening agent, so that lactic acid and acetic acid are produced after fermentation in the intestinal tracts, the utilization rate of calcium, phosphorus and iron can be improved, the absorption of iron and vitamins can be promoted, vitamin K and vitamin B are produced, the absorption of cholesterol can be reduced, the function of inhibiting the growth of harmful bacteria is realized, the dysbacteriosis in vivo can be regulated, the generation of toxin in vivo can be reduced, and the detoxification burden of livers is reduced.
The invention also provides a preparation method of the milk powder for improving immunity, which comprises the following steps:
(1) weighing the raw materials according to the parts by weight of the milk powder for improving immunity;
(2) stirring fructus Lycii powder, ganoderan, concentrated lactalbumin, lactose, galactooligosaccharide, lactoferrin, yeast beta-glucan and taurine, mixing well, pulverizing, and sieving to obtain premixed powder;
(3) adding skimmed milk powder, whole milk powder, bovine colostrum powder, compound vitamins, compound minerals and compound probiotics into the premixed powder, and stirring to mix well to obtain the milk powder for improving immunity.
The invention has the beneficial effects that:
the preparation method has simple process, easy operation and low production cost, and is suitable for wide production and application.
Further, in the step (2), the preparation method of the ganoderma lucidum polysaccharide comprises the following steps:
A. cleaning Ganoderma encarpium, drying to constant weight, crushing, and sieving with 100-mesh and 200-mesh sieve to obtain Ganoderma powder;
B. adding 6-8 times of anhydrous ethanol into Ganoderma powder, stirring for 1-2 hr, filtering, and collecting residue;
C. adding 6-8 times of distilled water and 1% -5% of cellulase by mass into ganoderma lucidum filter residue, stirring for 2-3h, filtering, collecting filtrate, concentrating under reduced pressure, precipitating with alcohol, washing with anhydrous ethanol, and purifying to obtain the ganoderma lucidum polysaccharide.
Further, in the step (2), the stirring speed is 80-120r/min, and the time is 10-20 min.
The beneficial effects of the further technical scheme are that: the accurate stirring parameters ensure that the raw materials are uniformly mixed, and the quality of the premixed powder product is uniform and stable.
Furthermore, in the step (2), the mesh number of the sieve is 100-200 meshes.
The beneficial effects of the further technical scheme are that: the raw materials are crushed, so that the milk powder has fine quality, the mouthfeel is enhanced, and the nutrient components are easier to be absorbed by a human body.
Further, in the step (3), the stirring speed is 50-100r/min, and the time is 20-30 min.
The beneficial effects of the further technical scheme are that: the accurate mixing parameters enable the raw materials to be uniformly mixed, and the milk powder product for improving the immunity has uniform and stable quality.
In summary, compared with the prior art, the invention has the following beneficial effects:
the raw materials are compounded and cooperated, and various nutrient elements necessary for human bodies are added, so that the milk powder is rich in protein and nutrition, particularly, the medlar powder and the ganoderma lucidum polysaccharide are added, the composition of carbohydrate is improved under the condition of not influencing the sensory characteristics, the immune effect of the milk powder is enhanced, the milk powder has good activity function, the physique of a user can be improved, and the immunity resistance is enhanced.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
The milk powder for improving immunity comprises the following raw materials by weight: 400kg of skimmed milk powder, 100kg of whole milk powder, 50kg of bovine colostrum powder, 20kg of Chinese wolfberry powder, 10kg of ganoderma lucidum polysaccharide, 10kg of concentrated whey protein, 2kg of lactose, 1kg of galacto-oligosaccharide, 0.5kg of lactoferrin, 0.3kg of yeast beta-glucan, 0.3kg of taurine, 0.1kg of vitamin complex, 0.5kg of compound mineral substances and 0.2kg of compound probiotics;
wherein 0.1kg of the compound vitamin contains 0.012kg of L-ascorbic acid sodium, 0.018kg of dl-alpha-tocopherol acetate, 0.020kg of vitamin A acetate, 0.025kg of cholecalciferol and 0.025kg of pyridoxine hydrochloride;
0.5kg of composite mineral contains 0.3kg of ferric pyrophosphate and 0.2kg of zinc sulfate;
0.2kg of composite probiotics contains 1 × 10 bacteria80.1kg of Bifidobacterium animalis per gram and 1 × 10 bacteria content80.1kg of Lactobacillus acidophilus of CFU/g;
The preparation method of the milk powder for improving immunity comprises the following steps:
(1) weighing the raw materials according to the weight of the milk powder for improving immunity;
(2) stirring fructus Lycii powder, Ganoderma polysaccharide, concentrated lactalbumin, lactose, galactooligosaccharide, lactoferrin, yeast beta-dextran and taurine at 80r/min for 20min, mixing well, pulverizing, and sieving with 100 mesh sieve to obtain premixed powder;
the preparation method of the ganoderma lucidum polysaccharide comprises the following steps: A. cleaning Ganoderma encarpium, oven drying to constant weight, crushing, and sieving with 100 mesh sieve to obtain Ganoderma powder; B. adding absolute ethyl alcohol with the mass being 6 times that of the ganoderma lucidum powder, stirring for 1 hour, filtering, and collecting filter residues; C. adding 6 times of distilled water and 1% of cellulase by mass into the ganoderma lucidum filter residue, stirring for 2h, filtering, collecting the filtrate, concentrating under reduced pressure, precipitating with alcohol, washing with anhydrous ethanol, and purifying to obtain ganoderma lucidum polysaccharide;
(3) adding skimmed milk powder, whole milk powder, bovine colostrum powder, compound vitamins, compound minerals and compound probiotics into the premixed powder, and stirring at a speed of 50r/min for 30min until the mixture is uniform to obtain the milk powder for improving immunity.
Example 2
The milk powder for improving immunity comprises the following raw materials by weight: 500kg of skimmed milk powder, 150kg of whole milk powder, 80kg of bovine colostrum powder, 30kg of Chinese wolfberry powder, 15kg of ganoderma lucidum polysaccharide, 12kg of concentrated whey protein, 5kg of lactose, 2kg of galacto-oligosaccharide, 0.6kg of lactoferrin, 0.8kg of yeast beta-glucan, 0.4kg of taurine, 0.2kg of vitamin complex, 1.2kg of compound mineral substances and 0.6kg of compound probiotics;
wherein 0.2kg of the compound vitamin comprises 0.024kg of L-sodium ascorbate, 0.036kg of dl-alpha-tocopherol acetate, 0.040kg of vitamin A acetate, 0.050kg of cholecalciferol and 0.050kg of pyridoxine hydrochloride;
1.2kg of the compound mineral comprises 0.8kg of ferric pyrophosphate and 0.4kg of zinc sulfate;
0.6kg of composite probiotics contains 1 × 10 bacteria80.3kg of Bifidobacterium animalis per gram and 1 × 10 bacteria content8CFU/g Lactobacillus acidophilus 0.3kg;
The preparation method of the milk powder for improving immunity comprises the following steps:
(1) weighing the raw materials according to the weight of the milk powder for improving immunity;
(2) stirring fructus Lycii powder, Ganoderma polysaccharide, concentrated lactalbumin, lactose, galactooligosaccharide, lactoferrin, yeast beta-dextran and taurine at 100r/min for 15min, mixing well, pulverizing, and sieving with 150 mesh sieve to obtain premixed powder;
the preparation method of the ganoderma lucidum polysaccharide comprises the following steps: A. cleaning Ganoderma encarpium, oven drying to constant weight, crushing, and sieving with 150 mesh sieve to obtain Ganoderma powder; B. adding 7 times of anhydrous ethanol into Ganoderma powder, stirring for 1.5 hr, filtering, and collecting residue; C. adding 7 times of distilled water and 3% of cellulase by mass into the ganoderma lucidum filter residue, stirring for 2.5h, filtering, collecting the filtrate, concentrating under reduced pressure, precipitating with alcohol, washing with anhydrous ethanol, and purifying to obtain ganoderma lucidum polysaccharide;
(3) adding skimmed milk powder, whole milk powder, bovine colostrum powder, compound vitamins, compound minerals and compound probiotics into the premixed powder, and stirring at 80r/min for 25min to mix uniformly to obtain the milk powder for improving immunity.
Example 3
The milk powder for improving immunity comprises the following raw materials by weight: 600kg of skimmed milk powder, 200kg of whole milk powder, 100kg of bovine colostrum powder, 40kg of Chinese wolfberry powder, 20kg of ganoderma lucidum polysaccharide, 15kg of concentrated whey protein, 6kg of lactose, 3kg of galacto-oligosaccharide, 0.7kg of lactoferrin, 1.1kg of yeast beta-glucan, 0.5kg of taurine, 0.3kg of vitamin complex, 2kg of compound mineral substances and 1kg of compound probiotics;
wherein 0.3kg of the compound vitamin contains 0.036kg of L-sodium ascorbate, 0.054kg of dl-alpha-tocopherol acetate, 0.060kg of vitamin A acetate, 0.075kg of cholecalciferol and 0.075kg of pyridoxine hydrochloride;
2kg of the compound mineral contains 1.2kg of ferric pyrophosphate and 0.8kg of zinc sulfate;
1kg of composite probiotics contains 1 x 10 bacteria80.5kg of Bifidobacterium animalis per gram and 1 × 10 bacteria content8CFU/g Lactobacillus acidophilus 0.5kg;
The preparation method of the milk powder for improving immunity comprises the following steps:
(1) weighing the raw materials according to the weight of the milk powder for improving immunity;
(2) stirring fructus Lycii powder, ganoderan, concentrated lactalbumin, lactose, galactooligosaccharide, lactoferrin, yeast beta-glucan and taurine at 120r/min for 10min, mixing well, pulverizing, and sieving with 200 mesh sieve to obtain premixed powder;
the preparation method of the ganoderma lucidum polysaccharide comprises the following steps: A. cleaning Ganoderma encarpium, oven drying to constant weight, crushing, and sieving with 200 mesh sieve to obtain Ganoderma powder; B. adding absolute ethyl alcohol with the mass being 8 times that of the ganoderma lucidum powder, stirring for 2 hours, filtering, and collecting filter residues; C. adding 8 times of distilled water and 5% of cellulase by mass into the ganoderma lucidum filter residue, stirring for 3h, filtering, collecting the filtrate, concentrating under reduced pressure, precipitating with alcohol, washing with anhydrous ethanol, and purifying to obtain ganoderma lucidum polysaccharide;
(3) adding skimmed milk powder, whole milk powder, bovine colostrum powder, compound vitamins, compound minerals and compound probiotics into the premixed powder, and stirring at 100r/min for 20min until mixing uniformly to obtain the milk powder for improving immunity.
Comparative example 1
The milk powder for improving immunity is different from the milk powder in example 2 only in that the medlar powder is not contained.
Comparative example 2
The milk powder for improving immunity is different from the milk powder in example 2 only in that no ganoderan is contained.
Performance testing
1. Analysis of nutrient composition
The milk powders with improved immunity prepared in examples 1-3 were analyzed for their nutritional components, and the average values of the individual components are shown in Table 1.
TABLE 1 nutrient profile of milk powder of examples 1-3
As can be seen from Table 1, the milk powder for improving immunity prepared in the embodiments 1-3 of the present invention has various nutritional indexes meeting the corresponding requirements, and can meet the daily needs of human body.
2. Efficacy test
60 male KM mice (provided by Shanghai Slek laboratory animals, Inc.) at 5-6 weeks of age were collected and divided into 6 groups on average. Wherein, the 1 st to 5 th groups are respectively drenched with sterile water containing dissolved milk powder of examples 1 to 3 and comparative examples 1 to 2, and the 6 th group (blank control group) is drenched with sterile water with the same volume for 1 time every day for 30 days.
Each group was injected intraperitoneally with 1mL of 5% chicken red blood cell suspension on day 38 of the experiment. After 30min, the mice were sacrificed by cervical dislocation. lmL physiological saline was injected into the abdominal cavity, the abdomen of the mouse was gently kneaded for 1 minute, the skin of the abdominal wall was cut, the upper opening of the muscle layer was made, and the abdominal cavity fluid lmL was sucked up by inserting a pipette into the abdominal cavity and dropped on a clean slide glass. The slides were placed in an enamel box lined with wet gauze and then incubated in a 37 ℃ incubator for 30 minutes. And taking out the glass slide, rinsing to remove the supernatant and the cells which are not adhered to the glass slide, then drying at room temperature, fixing with a 1:1 acetone/methanol solution, placing in a Giemsa staining solution, carrying out dip staining for 15-30min, then washing with water and drying in the air. Macrophages were counted under high power microscope, 100 per slide, and percent phagocytosis and index of phagocytosis were calculated, respectively, and the results are shown in table 2.
Wherein the percent (%) phagocytosis is the number of macrophages that phagocytose chicken red blood cells/number of macrophages counted × 100; phagocytosis index is the total number of chicken erythrocytes phagocytosed per number of macrophages counted.
TABLE 2 Effect of groups of samples on phagocytic function of mouse macrophages
Group of | Percentage of phagocytosis (%) | Phagocytic index |
Blank control group | 32.5 | 0.41 |
Example 1 | 53.2 | 0.61 |
Example 2 | 55.1 | 0.63 |
Example 3 | 50.8 | 0.58 |
Comparative example 1 | 38.6 | 0.46 |
Comparative example 2 | 40.5 | 0.49 |
As can be seen from Table 2, the percent phagocytosis and the phagocytosis index of examples 1-3 of the present invention were significantly higher than those of the blank control and comparative examples 1-2.
The tests show that the milk powder can obviously improve the phagocytic function of mouse abdominal cavity macrophages, and the effect is superior to that of a comparative example.
The description of the disclosed embodiments is provided to enable any person skilled in the art to make or use the present invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments without departing from the spirit or scope of the invention. Thus, the present invention is not intended to be limited to the embodiments shown herein but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
Claims (10)
1. The milk powder for improving immunity is characterized by comprising the following raw materials in parts by weight: 400 portions of skimmed milk powder, 200 portions of whole milk powder, 50 to 100 portions of bovine colostrum powder, 20 to 40 portions of medlar powder, 10 to 20 portions of ganoderma lucidum polysaccharide, 10 to 15 portions of concentrated whey protein, 2 to 6 portions of lactose, 1 to 3 portions of galacto-oligosaccharide, 0.5 to 0.7 portion of lactoferrin, 0.3 to 1.1 portion of yeast beta-glucan, 0.3 to 0.5 portion of taurine, 0.1 to 0.3 portion of vitamin complex, 0.5 to 2 portions of compound mineral substances and 0.2 to 1 portion of compound probiotics.
2. The milk powder for improving immunity according to claim 1, which is characterized by comprising the following raw materials in parts by weight: 500 parts of skimmed milk powder, 150 parts of whole milk powder, 80 parts of bovine colostrum powder, 30 parts of medlar powder, 15 parts of ganoderan, 12 parts of concentrated whey protein, 5 parts of lactose, 2 parts of galacto-oligosaccharide, 0.6 part of lactoferrin, 0.8 part of yeast beta-glucan, 0.4 part of taurine, 0.2 part of vitamin complex, 1.2 parts of compound mineral substances and 0.6 part of compound probiotics.
3. The milk powder for improving immunity according to claim 1 or 2, wherein the vitamin complex is at least one of sodium L-ascorbate, dl-alpha-tocopheryl acetate, vitamin A acetate, cholecalciferol and pyridoxine hydrochloride.
4. The milk powder for improving immunity according to claim 1 or 2, wherein the compound mineral is ferric pyrophosphate and/or zinc sulfate.
5. The milk powder for improving immunity according to claim 1 or 2, wherein the complex probiotics are animal bifidobacteria and/or lactobacillus acidophilus;
the strain content of Bifidobacterium animalis is 1 × 106-1×108CFU/g;
The bacteria content of the lactobacillus acidophilus is 1 multiplied by 106-1×108CFU/g。
6. The preparation method of the milk powder for improving immunity is characterized by comprising the following steps:
(1) weighing the raw materials according to the parts by weight of the milk powder for improving immunity of any one of claims 1 to 3;
(2) stirring fructus Lycii powder, ganoderan, concentrated lactalbumin, lactose, galactooligosaccharide, lactoferrin, yeast beta-glucan and taurine, mixing well, pulverizing, and sieving to obtain premixed powder;
(3) adding skimmed milk powder, whole milk powder, bovine colostrum powder, compound vitamins, compound minerals and compound probiotics into the premixed powder, and stirring to mix uniformly to obtain the milk powder for improving immunity.
7. The method for preparing milk powder for improving immunity according to claim 6, wherein in the step (2), the method for preparing ganoderan comprises the following steps:
A. cleaning Ganoderma encarpium, drying to constant weight, crushing, and sieving with 100-mesh and 200-mesh sieve to obtain Ganoderma powder;
B. adding 6-8 times of anhydrous ethanol into Ganoderma powder, stirring for 1-2 hr, filtering, and collecting residue;
C. adding 6-8 times of distilled water and 1% -5% of cellulase by mass into ganoderma lucidum filter residue, stirring for 2-3h, filtering, collecting filtrate, concentrating under reduced pressure, precipitating with alcohol, washing with anhydrous ethanol, and purifying to obtain the ganoderma lucidum polysaccharide.
8. The method for preparing milk powder with improved immunity according to claim 6, wherein in step (2), the stirring speed is 80-120r/min and the stirring time is 10-20 min.
9. The method as claimed in claim 6, wherein in step (2), the mesh number of the sieved mesh is 100-200 meshes.
10. The method for preparing milk powder with improved immunity according to claim 6, wherein in step (3), the stirring speed is 50-100r/min and the stirring time is 20-30 min.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110113235.1A CN112753777A (en) | 2021-01-27 | 2021-01-27 | Milk powder for improving immunity and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110113235.1A CN112753777A (en) | 2021-01-27 | 2021-01-27 | Milk powder for improving immunity and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112753777A true CN112753777A (en) | 2021-05-07 |
Family
ID=75706154
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110113235.1A Pending CN112753777A (en) | 2021-01-27 | 2021-01-27 | Milk powder for improving immunity and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112753777A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114145352A (en) * | 2021-11-30 | 2022-03-08 | 广州麦乐生物科技有限公司 | Adult formula milk powder for preventing cancer and preparation method and application thereof |
CN114732051A (en) * | 2022-03-10 | 2022-07-12 | 广州麦乐生物科技有限公司 | Adult formula milk powder for reconstructing and strengthening human body immunity |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102499291A (en) * | 2011-12-28 | 2012-06-20 | 内蒙古伊利实业集团股份有限公司 | Milk powder with functions of maintaining beauty and keeping young and improving immunity of organism and preparation method thereof |
CN104982534A (en) * | 2015-05-08 | 2015-10-21 | 苏州葛家坞生物科技有限公司 | Ganoderma lucidum polysaccharide-containing infant formula milk powder |
CN111011522A (en) * | 2020-02-27 | 2020-04-17 | 青岛索康食品有限公司 | Children formula milk powder capable of improving immunity and preparation method thereof |
CN111758792A (en) * | 2020-07-27 | 2020-10-13 | 广州班护生物科技有限公司 | Milk powder for improving resistance and promoting growth and production method thereof |
CN112244095A (en) * | 2020-10-22 | 2021-01-22 | 成都诺臻生物科技有限公司 | Milk powder for regulating immunity and preparation method thereof |
-
2021
- 2021-01-27 CN CN202110113235.1A patent/CN112753777A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102499291A (en) * | 2011-12-28 | 2012-06-20 | 内蒙古伊利实业集团股份有限公司 | Milk powder with functions of maintaining beauty and keeping young and improving immunity of organism and preparation method thereof |
CN104982534A (en) * | 2015-05-08 | 2015-10-21 | 苏州葛家坞生物科技有限公司 | Ganoderma lucidum polysaccharide-containing infant formula milk powder |
CN111011522A (en) * | 2020-02-27 | 2020-04-17 | 青岛索康食品有限公司 | Children formula milk powder capable of improving immunity and preparation method thereof |
CN111758792A (en) * | 2020-07-27 | 2020-10-13 | 广州班护生物科技有限公司 | Milk powder for improving resistance and promoting growth and production method thereof |
CN112244095A (en) * | 2020-10-22 | 2021-01-22 | 成都诺臻生物科技有限公司 | Milk powder for regulating immunity and preparation method thereof |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114145352A (en) * | 2021-11-30 | 2022-03-08 | 广州麦乐生物科技有限公司 | Adult formula milk powder for preventing cancer and preparation method and application thereof |
CN114732051A (en) * | 2022-03-10 | 2022-07-12 | 广州麦乐生物科技有限公司 | Adult formula milk powder for reconstructing and strengthening human body immunity |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100813914B1 (en) | The conversion and modification of natural medicines by intestinal probiotics co-fermentation cultures | |
KR101539382B1 (en) | Food composition for improvement of bowel function and relief of constipation | |
CN112753777A (en) | Milk powder for improving immunity and preparation method thereof | |
KR101487542B1 (en) | An manufacturing method of ginseng polysaccharide for immunopotentiating and compositions comprising thereof | |
CN109007037A (en) | A kind of composition and products thereof enhancing infant immunity and application | |
CN105768106A (en) | Liver nutrition improving functional food | |
CN108785331A (en) | It is a kind of that there is qi-blood tonifying composition and its preparation method and application | |
CN113632851A (en) | Multifunctional children growth milk powder and preparation method thereof | |
CN112890064A (en) | Composite collagen peptide solid beverage and preparation method thereof | |
CN109223603B (en) | Preparation method of composition for treating alopecia | |
CN109527099A (en) | A kind of fructus lycii compound probiotic goat milk piece and preparation method thereof | |
CN105725196A (en) | Blueberry enzyme slice and preparation method thereof | |
CN108795823A (en) | It is a kind of improve women pregnant and lying-in women's intestinal flora probiotics cultural method and application | |
CN100506050C (en) | Method for preparing stomach-benefiting, digestion-promoting yoghurt comprising micron pine pollen, fig, chickens gizzard-membrane etc. | |
CN113519624A (en) | Nutritional formula for improving immunity and antiviral ability of astronauts and preparation method | |
CN111449247A (en) | Tumor patient sea cucumber peptide nutritional supplement and processing method thereof | |
CN106235321A (en) | A kind of composite plant ferment and application thereof | |
CN107536061B (en) | Composite probiotic dietary fiber and preparation method thereof | |
CN100479671C (en) | Method for preparing sour milk containing composite micron pollen pini and konjak for reducing-weight and lowering-blood sugar | |
CN100350846C (en) | Method for preparing sour milk contg. micron ginseng and antler etc. with tonifying-kidney and eliminating fatigue functions | |
CN114984065A (en) | Probiotic composition for improving immunity and preparation method thereof | |
CN114145352A (en) | Adult formula milk powder for preventing cancer and preparation method and application thereof | |
CN105852077A (en) | Fungus and probiotic compounding functional food | |
CN100469253C (en) | Method for preparing tumor mutation-resisting yoghourt with micron ash tree pollen, pine pollen, bee pollen and ganoderma lucidum spore powder | |
CN112753775A (en) | Anti-inflammation milk powder and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210507 |